Silence Therapeutics plc
NASDAQSLN enters September with a striking split personality: the stock is up 31% over the past month and 9% on the week, yet short interest has climbed roughly 55% in the same 30-day window — a rare setup where momentum buyers and fresh bears are piling in simultaneously. The positioning picture is more nuanced than the headline numbers suggest. Short interest has risen sharply — from…
Snapshot as of 26 Sept 2026
SLN enters September with a striking split personality: the stock is up 31% over the past month and 9% on the week, yet short interest has climbed roughly 55% in the same 30-day window — a rare setup where momentum…
Silence Therapeutics beat earnings on August 10. The stock jumped 23% that day. Now the options market is repricing the trade. The put/call ratio hit 0.49 on August 11. That is 2.5 standard deviations above the 20-day…
Silence Therapeutics heads into its August 12 results with the stock in the middle of one of its sharpest rallies in recent memory — and the insider register telling a story that cuts against the bullish momentum. The…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for SLN — free to start on ORTEX.
Sign up for free →Open SLN on ORTEX